PubMedCrossRef 16 Lintges M, van

der Linden M, Hilgers R

PubMedCrossRef 16. Lintges M, van

der Linden M, Hilgers R-D, Arlt S, Al-Lahham A, Reinert RR, Plücken S, Rink L: Superantigen genes are more important than the emm type for the invasiveness of group A Streptococcus infection. GDC-0449 purchase J Infect Dis 2010, 202:20–28.PubMedCrossRef 17. Friães A, Ramirez M, Melo-Cristino J, the Portuguese Group for the Study of Streptococcal Infections: Nonoutbreak surveillance of group A streptococci causing invasive disease in Portugal identified internationally disseminated clones among members of a genetically heterogeneous population. J Clin Microbiol 2007, 45:2044–2047.PubMedCrossRef 18. Friães A, Pinto FR, Silva-Costa C, Ramirez M, Melo-Cristino J: Superantigen gene complement of Streptococcus pyogenes-relationship with other typing methods and short-term stability. Eur J Clin Microbiol Infect Dis 2012. In press. (http://​dx.​doi.​org/​10.​1007/​s10096-012-1726-3) PCI 32765 19. Cockerill FR, MacDonald KL, Thompson RL, Roberson F, Kohner PC, Besser-Wiek J, Manahan JM, Musser JM, Schlievert PM, Talbot J, Frankfort B, Steckelberg JM, Wilson WR, Osterholm MT: An outbreak of invasive group A streptococcal

disease associated with high carriage rates of the invasive clone among school-aged children. JAMA 1997, 277:38–43.PubMedCrossRef 20. Fiorentino TR, Beall B, Mshar P, Bessen DE: A genetic-based evaluation of the principal tissue reservoir for group A streptococci isolated from normally sterile sites. J Infect Dis 1997, 176:177–182.PubMedCrossRef 21. Ayer V, Tewodros W, selleck chemicals Manoharan A, Skariah S, Luo F, Bessen DE: Tetracycline resistance in group A streptococci: emergence on a global scale and influence on multiple-drug resistance.

Antimicrob Agents Chemother 2007, 51:1865–1868.PubMedCrossRef 22. Nielsen HUK, Hammerum AM, Ekelund K, Bang D, Pallesen LV, Frimodt-Møller N: Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes? selleck Microb Drug Resist 2004, 10:231–238.PubMed 23. Malhotra-Kumar S, Wang S, Lammens C, Chapelle S, Goossens H: Bacitracin-resistant clone of Streptococcus pyogenes isolated from pharyngitis patients in Belgium. J Clin Microbiol 2003, 41:5282–5284.PubMedCrossRef 24. Mihaila-Amrouche L, Bouvet A, Loubinoux J: Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics. J Clin Microbiol 2004, 42:3844–3846.PubMedCrossRef 25. York MK, Gibbs L, Perdreau-Remington F, Brooks GF: Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California. J Clin Microbiol 1999, 37:1727–1731.PubMed 26. Pires R, Rolo D, Mato R, Feio de Almeida J, Johansson C, Henriques-Normark B, Morais A, Brito-Avô A, Gonçalo-Marques J, Santos-Sanches I: Resistance to bacitracin in Streptococcus pyogenes from oropharyngeal colonization and noninvasive infections in Portugal was caused by two clones of distinct virulence genotypes.

Comments are closed.